Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Hospitals & Diagnostics
    • Aster DM Healthcare...

    Aster DM Healthcare shares down over 5 percent in debut trade

    Written by Ruby Khatun Khatun Published On 2018-02-27T10:30:28+05:30  |  Updated On 27 Feb 2018 10:30 AM IST
    Aster DM Healthcare shares down over 5 percent in debut trade

    New Delhi: Shares of Aster DM Healthcare made a weak debut at the bourses, ending over 5 percent down from the issue price of Rs 190.


    The stock listed at Rs 182.10, a loss of 4.15 percent from the issue price, on BSE. During the day, it tanked 7.13 per cent to Rs 176.45. It finally ended at Rs 179.85, down 5.34 percent.



    At NSE, shares of the company lost 4.44 percent to close at Rs 181.55.

    In terms of equity volume, 18.26 lakh shares were traded on BSE and over one crore shares changed hands at NSE during the day.


    The company's market valuation stood at Rs 9,086.51 crore.


    The initial public offer of Aster DM Healthcare was subscribed 1.33 times during February 12-15.


    The price band for the offer was kept at Rs 180-190 per share.


    The company operates in India, the Philippines, Jordan and all the Gulf Cooperation Council (GCC) states comprising the United Arab Emirates, Oman, Saudi Arabia, Qatar, Kuwait, and Bahrain.

    Aster DMAster DM Healthcaredebut tradedownGulf Cooperation CouncilIndiainitial public offerKuwaitPhilippinesSaudi ArabiaSharesUnited Arab Emirates
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok